As mentioned above, the average age at onset, the risk of colorectal cancer and the tumor phenotype in EPCAM deletion carriers are comparable to those carrying a typical mismatch repair gene mutation in MLH1 or MSH2, whereas the cumulative risk of endometrial cancer is much lower [5,20]. Here, MSH2 is linked to neoplasm.